Abstract:NAD(P)H:quinone oxidoreductase 1 (NQO1) has been shown to be a potential therapeutic target for various human diseases, such as cancer and neurodegenerative disorders. Recent advances in computational methods, especially network-based methods, have made it possible to identify novel compounds for a target with high efficiency and low cost. In this study, we designed a workflow combining network-based methods and identification of privileged substructures to discover new compounds targeting NQO1 from a natural product library. According to the prediction results, we purchased 56 compounds for experimental validation. Without the assistance of privileged substructures, 31 compounds (31/56 = 55.4%) showed IC<sub>50</sub> < 100 μM, and 11 compounds (11/56 = 19.6%) showed IC<sub>50</sub> < 10 μM. With the assistance of privileged substructures, the two success rates were increased to 61.8 and 26.5%, respectively. Seven natural products further showed inhibitory activity on NQO1 at the cellular level, which may serve as lead compounds for further development. Moreover, network analysis revealed that osthole may exert anticancer effects against multiple cancer types by inhibiting not only carbonic anhydrases IX and XII but also NQO1. Our workflow and computational methods can be easily applied in other targets and become useful tools in drug discovery and development.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.1c00260?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.1c00260</a>.Detailed information of the drugs used for network construction; detailed information of the targets used for network construction; detailed information of the DTIs used for network construction; statistics of the drug–substructure associations used for model construction; optimized parameters of global bSDTNBI models; evaluation indicators of our network-based models in 10-fold cross validation; target proteins predicted to 4027 compounds by the best model Global-bSDTNBI-FCFP_4; detailed information of the 86 compounds predicted to target NQO1 by the best model Global-bSDTNBI-FCFP_4; including the 56 compounds purchased for experimental validation; and ADMET properties predicted to the seven newly discovered NQO1 inhibitors (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.1c00260/suppl_file/ci1c00260_si_001.xlsx">XLSX</a>)This article has not yet been cited by other publications.

In Silico Analysis of Antioxidant Phytochemicals with Potential NADPH Oxidase Inhibitory Effect

Investigation of NADPH-Oxidase’s Binding Subunit(s) for Catechin Compounds Induce Inhibition

The POTENTIAL OF BUTTERFLY PEA FLOWER METHANOL EXTRACT AS AN ANTIOXIDANT BY IN SILICO

Design, Synthesis, and Biological Evaluation of Quinoline (Quinolinone) Derivatives as NADPH Oxidase (NOX) Inhibitors

Computational Assessment of Carotenoids as Keap1-Nrf2 Protein–Protein Interaction Inhibitors: Implications for Antioxidant Strategies

In Vitro and in Silico Xanthine Oxidase Inhibitory Activity of Selected Phytochemicals Widely Present in Various Edible Plants.

Identification of novel human neutrophil elastase inhibitors from dietary phytochemicals using in silico and in vitro studies

A Model of Interaction Between Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Apocynin Analogues by Docking Method.

Discovery of Keap1−Nrf2 small−molecule inhibitors from phytochemicals based on molecular docking

3D and 2D-QSAR Studies on Natural Flavonoids for Nitric Oxide Production Inhibitory Activity

The antityrosinase and antioxidant activities of flavonoids dominated by the number and location of phenolic hydroxyl groups

Prediction of ADMET, molecular docking, DFT, and QSPR of potential phytoconstituents from Ambrosia maritima L. targeting xanthine oxidase

NADPH Oxidase Inhibition of Novel Apocynin Dimer Derivatives

An In Silico Molecular Modelling-Based Prediction of Potential Keap1 Inhibitors from Hemidesmus indicus (L.) R.Br. against Oxidative-Stress-Induced Diseases

Discovery of Natural Products Targeting NQO1 via an Approach Combining Network-Based Inference and Identification of Privileged Substructures

Interaction of dicaffeoylquinic derivatives with peroxynitrite and other reactive nitrogen species

Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects

Development of a Novel Nitric Oxide (NO) Production Inhibitor with Potential Therapeutic Effect on Chronic Inflammation

Comprehensive In Silico Analysis of Uncaria Tomentosa Extract: Chemical Profiling, Antioxidant Assessment, and CLASP Protein Interaction for Drug Design in Neurodegenerative Diseases

In Silico Analysis of the NPC1L1 Inhibitor of Catechins from Green Tea

Molecular Docking Studies of ROS Agent from Quinone Family to Reductase Enzymes:Implication in Finding Anticancer Drug Candidate